Drug Shortage Report for MAR-TADALAFIL

Last updated on 2020-01-04 History
Report ID 99682
Drug Identification Number 02452243
Brand name MAR-TADALAFIL
Common or Proper name Tadalafil
Company Name MARCAN PHARMACEUTICALS INC
Market Status MARKETED
Active Ingredient(s) TADALAFIL
Strength(s) 20MG
Dosage form(s) TABLET
Route of administration ORAL
Packaging size 4 Tablets
ATC code G04BE
ATC description OTHER UROLOGICALS, INCL ANTISPASMODICS
Reason for shortage Demand increase for the drug.
Anticipated start date 2019-11-29
Actual start date 2019-11-28
Estimated end date 2020-01-03
Actual end date 2020-01-03
Shortage status Resolved
Updated date 2020-01-04
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 2 GURDWARA RD., SUITE 112
OTTAWA, ONTARIO
CANADA K2E 1A2
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v14 2020-01-04 English Compare
v13 2020-01-02 French Compare
v12 2020-01-02 English Compare
v11 2019-12-19 French Compare
v10 2019-12-19 English Compare
v9 2019-12-19 French Compare
v8 2019-12-19 English Compare
v7 2019-12-16 French Compare
v6 2019-12-16 English Compare
v5 2019-11-29 English Compare
v4 2019-11-27 French Compare
v3 2019-11-27 English Compare
v2 2019-11-26 French Compare
v1 2019-11-26 English Compare

Showing 1 to 14 of 14